Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.2760
+0.0040 (1.47%)
At close: Jan 30, 2026

Revenue by Product

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '19
Early-stage Cancer Diagnostic Technology Platform
154.22K
Early-stage Cancer Diagnostic Technology Platform Growth
-5.52%

Revenue by Geography

Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '19
Canada
154.22K
Canada Growth
-5.52%